Elevance Health Q3 Earnings Beat Street Estimates, Lifts FY22 Profit Guidance
Elevance Health Inc (NYSE:ELV) reported Q3 FY22 adjusted EPS of $7.53, up 10.9% Y/Y, beating the consensus of $7.16. Operating…
Recap: Elevance Health Q3 Earnings
Elevance Health (NYSE:ELV) reported its Q3 earnings results on Wednesday, October 19, 2022 at 06:00 AM.
Here's what investors need to know about the announcement.
Why Analysts Love This High Yield Health Care Stock, Which Just Changed Its Name
Elevance Health Inc (NYSE: ELV) (previously known as Anthem) remains one of the leading health insurers in the U.S., providing medical benefits to roughly 45 million medical members.
How Is The Market Feeling About Elevance Health?
Elevance Health's (NYSE:ELV) short percent of float has fallen 4.4% since its last report. The company recently reported that it has 2.08 million shares sold short, which is 0.87% of all regular shares that are available for trading.
B of A Securities Upgrades Elevance Health to Buy, Raises Price Target to $575
B of A Securities analyst Kevin Fischbeck upgrades Elevance Health (NYSE:ELV) from Neutral to Buy and raises the price target from $535 to $575.
SVB Leerink Upgrades Elevance Health to Outperform, Raises Price Target to $580
SVB Leerink analyst Whit Mayo upgrades Elevance Health (NYSE:ELV) from Market Perform to Outperform and raises the price target from $490 to $580.
Morgan Stanley Maintains Equal-Weight on Elevance Health, Lowers Price Target to $485
Morgan Stanley analyst Ricky Goldwasser maintains Elevance Health (NYSE:ELV) with a Equal-Weight and lowers the price target from $533 to $485.